文献速递传染病防控与疫情报告免疫规划妇幼与学校卫生

2023-2024年美国流感相关并发症高风险儿童和青少年抗病毒治疗利用不足

Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications - United States, 2023-2024.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2024-11-14

基于美国两个流感监测网络数据,分析18岁以下确诊流感且推荐抗病毒治疗的儿童和青少年。2017-18至2023-2024流感季住院患者抗病毒治疗比例从70%-86%下降至2023-24季的52%-59%;2023-24季门诊高风险患者中仅31%接受处方。抗病毒治疗利用不足,所有住院儿童和青少年及门诊高风险者应尽早接受抗病毒治疗。

要点

  • 2017-18季住院流感患儿70%-86%接受抗病毒治疗,此后比例显著下降。
  • 2023-24季住院流感患儿仅52%-59%接受抗病毒治疗。
  • 2023-24季门诊高风险流感患儿中仅31%被处方抗病毒治疗。

核心结论

  • 流感抗病毒治疗在可受益的儿童和青少年中利用不足。
  • 所有住院儿童和青少年以及门诊高风险流感并发症患者,疑似或确诊流感时应尽快接受抗病毒治疗。

研究设计与样本

  • 利用美国两个儿童和青少年流感监测网络的数据,纳入18岁以下因实验室确诊流感就医且推荐抗病毒治疗的患者,计算接受治疗的比例。
  • 分析2017-18至2023-2024流感季住院流感儿童和青少年抗病毒治疗的趋势。

主要发现

  • 2017-18季住院流感儿童和青少年中70%-86%接受抗病毒治疗,此后比例显著下降。
  • 2023-24季住院流感儿童和青少年中52%-59%接受抗病毒治疗。
  • 2023-24季在一个网络中,门诊就诊的流感并发症高风险儿童和青少年中31%被处方抗病毒治疗。

临床怎么用

  • 所有住院儿童和青少年,以及门诊高风险流感并发症患者,疑似或确诊流感时应尽快接受抗病毒治疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Annually, tens of thousands of U.S. children and adolescents are hospitalized with seasonal influenza virus infection. Both influenza vaccination and early initiation of antiviral treatment can reduce complications of influenza. Using data from two U.S. influenza surveillance networks for children and adolescents aged <18 years with medically attended, laboratory-confirmed influenza for whom antiviral treatment is recommended, the percentage who received treatment was calculated. Trends in antiviral treatment of children and adolescents hospitalized with influenza from the 2017-18 to the 2023-2024 influenza seasons were also examined. Since 2017-18, when 70%-86% of hospitalized children and adolescents with influenza received antiviral treatment, the proportion receiving treatment notably declined. Among children and adolescents with influenza during the 2023-24 season, 52%-59% of those hospitalized received antiviral treatment. During the 2023-24 season, 31% of those at higher risk for influenza complications seen in the outpatient setting in one network were prescribed antiviral treatment. These findings demonstrate that influenza antiviral treatment is underutilized among children and adolescents who could benefit from treatment. All hospitalized children and adolescents, and those at higher risk for influenza complications in the outpatient setting, should receive antiviral treatment as soon as possible for suspected or confirmed influenza.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Frutos AM, Ahmad HM, Ujamaa D, et al. Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications - United States, 2023-2024. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39541236. doi:10.15585/mmwr.mm7345a2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。